Ozempic maker defends high U.S. price: It’s ‘helping’ reduce the cost of obesity

Ozempic maker defends high U.S. price: It’s ‘helping’ reduce the cost of obesity

The CEO of Novo Nordisk is defending the high cost of Ozempic and Wegovy in America, saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.
Read More

Leave a Reply

You were not leaving your cart just like that, right?

Enter your details below to save your shopping cart for later. And, who knows, maybe we will even send you a sweet discount code :)

Want to receive personalized offers?

Allow notifications to get real-time updates about your shopping cart and who knows, you may even receive a sweet discount code 😊

Maybe later